A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): Study protocol

BMJ Open

Volumn 4, Issue , 2014, Pages

  Fernando, Shavi ^a,b,c   Osianlis, Tiki ^b,d   Vollenhoven, Beverley ^b,c   Wallace, Euan ^a,b,c   Rombauts, Luk ^a,b,d  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH IVF   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MELATONIN; PLACEBO; 8-OXO-7-HYDRODEOXYGUANOSINE; ANTIOXIDANT; DEOXYGUANOSINE;

ADULT; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER FLOWMETRY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FEMALE INFERTILITY; HUMAN; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; OVARY FOLLICLE FLUID; OXIDATIVE STRESS; PATIENT CARE; PILOT STUDY; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECTS; FERTILIZATION; INFERTILITY, FEMALE; METHODOLOGY; OOCYTE; OVULATION INDUCTION; PHASE 2 CLINICAL TRIAL; PREGNANCY; PROCEDURES;

ANTIOXIDANTS; DEOXYGUANOSINE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FERTILIZATION; HUMANS; INFERTILITY, FEMALE; MELATONIN; OOCYTES; OVULATION INDUCTION; OXIDATIVE STRESS; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; RESEARCH DESIGN;

EID: 84940558360     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005986     Document Type: Article

References (60)

1. Kojo S. Vitamin C: basic metabolism and its function as an index of oxidative stress. Curr Med Chem 2004; 11:1041-64.
2. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007; 2:219-36.
3. Bouayed J, Bohn T. Exogenous antioxidants-double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 2010; 3:228-37.
4. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44-84.
5. Tamura H, Takasaki A, Taketani T, et al. The role of melatonin as an antioxidant in the follicle. J Ovarian Res 2012; 5:5.
6. Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update 2001; 7:175-89.
7. Yoshida M, Ishigati K, Nagai T, et al. Glutathione concentration during maturation and after fertilization in pig oocytes: relevance to the ability of oocytes to form male pronucleus. Biol Reprod 1993; 49:89-94.
8. Fatehi A, Roelen B, Colenbrander B, et al. Presence of cumulus cells during in vitro fertilization protects the bovine oocyte against oxidative stress and improves first cleavage but does not affect further development. Zygote 2005; 13:177-85.
9. Zeng H, Ren Z, Yeung W, et al. Low mitochondrial DNA and ATP contents contribute to the absence of birefringent spindle imaged with PolScope in in vitro matured human oocytes. Hum Reprod 2007; 22:1681-6.
10. Van Blerkom J, Davis P, Lee J. ATP content of human oocytes and developmental potential and outcome after in-vitro fertilization and embryo transfer. Hum Reprod 1995; 10:415-24.
11. Espey L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994; 50:233-8.
12. Tamura H, Takasaki A, Miwa I, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008; 44:280-7.
13. Tamura H, Taketani T, Takasaki A, et al. Influence of oxidative stress on oocyte quality and protective role of melatonin as an antioxidant. In: 20th World Congress on Fertility and Sterility, IFFS 2010. vol 7. Munich, Germany: Society for the Study of Reproduction, Inc. Journal fur Reproduktionsmedizin und Endokrinologie, 2010:366.
14. Reiter R, Rosales-Corral S, Manchester L, et al. Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci 2013; 14:7231-72.
15. Lord T, Nixon B, Jones KT, et al. Melatonin prevents postovulatory oocyte aging in the mouse and extends the window for optimal fertilization in vitro. Biol Reprod 2013; 88:67.
16. Wood S, Quinn A, Troupe S, et al. Seasonal variation in assisted conception cycles and the influence of photoperiodism on outcome in in vitro fertilization cycles. Hum Fertil 2006; 9:223-9.
17. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005; 3:28.
18. Srinivasan V, Spence W, Pandi-Perumal SR, et al. Melatonin and human reproduction: shedding light on the darkness hormone. Gynecol Endocrinol 2009; 25:779-85.
19. Dholpuria S, Vyas S, Purohit GN, et al. Sonographic monitoring of early follicle growth induced by melatonin implants in camels and the subsequent fertility. J Ultrasound 2012; 15:135-41.
20. Abecia JA, Palacin I, Forcada F, et al. The effect of melatonin treatment on the ovarian response of ewes to the ram effect. Domest Anim Endocrinol 2006; 31:52-62.
21. Rodriguez-Osorio N, Kim I, Wang H, et al. Melatonin increases cleavage rate of porcine preimplantation embryos in vitro. J Pineal Res 2007; 43:283-8.
22. Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, et al. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17:2070-95.
23. Ishizuka B, Kuribayashi Y, Murai K, et al. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res 2000; 28:48-51.
24. Choi J, Park S, Lee E, et al. Anti-apoptotic effect of melatonin on preimplantation development of porcine parthenogenetic embryos. Mol Reprod Dev 2008; 75:1127-35.
25. Kang J, Koo O, Kwon D, et al. Effects of melatonin on in vitro maturation of porcine oocyte and expression of melatonin receptor RNA in cumulus and granulosa cells. J Pineal Res 2009; 46:22-8.
26. Wei D, Zhang C, Xie J, et al. Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro. J Assist Reprod Genet 2013; 30:933-8.
27. Kim M, Park E, Kim H, et al. Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS? Reprod Biomed Online 2013; 26:22-9.
28. Knapen M, Zusterzeel P, Peters W, et al. Glutathione and glutathione-related enzymes in reproduction: a review. Eur J Obstet Gynecol Reprod Biol 1999; 82:171-84.
29. Eryilmaz O, Devran A, Sarikaya E, et al. Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems. J Assist Reprod Genet 2011; 28:815-20.
30. Batioglu A, Sahin U, Gürlek B, et al. The efficacy of melatonin administration on oocyte quality. Gynecol Endocrinol 2012; 28:91-3.
31. Taketani T, Tamura H, Takasaki A, et al. Protective role of melatonin in progesterone production by human luteal cells. J Pineal Res 2011; 51:207-13.
32. Manca ME, Manunta ML, Spezzigu A, et al. Melatonin deprival modifies follicular and corpus luteal growth dynamics in a sheep model. Reproduction 2014; 147:885-95.
33. Baratta M, Tamanini C. Effect of melatonin on the in vitro secretion of progesterone and estradiol 17 beta by ovine granulosa cells. Acta Endocrinol (Copenh) 1992; 127:366-70.
34. Wallace J, Robinson J, Wigzell S, et al. Effect of melatonin on the peripheral concentrations of LH and progesterone after oestrus, and on conception rate in ewes. J Endocrinol 1988; 119:523-30.
35. Zhang L, Chai M, Tian X, et al. Effects of melatonin on superovulation and transgenic embryo transplantation in small-tailed han sheep (Ovis aries). Neuro Endocrinol Lett 2013; 34:294-301.
36. Rizzo P, Raffone E, Benedetto V, et al. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci 2010; 14:555-61.
37. Nazzaro A, Salerno A, Marino S, et al. The addiction of melatonin to myo-inositol plus folic acid improve oocyte quality and pregnancy outcome in IVF cycle. A prospective clinical trial. Hum Reprod 2011; 26:i227.
38. Pacchiarotti A, Carlomagno G, Unfer V, et al. Role of myo-inositol and melatonin supplementation in follicular fluid of IVF patients with polycystic ovarian syndrome: a randomized controlled trial. ClinicalTrialsgov 2013; registration number: NCT01540747.
39. Unfer V, Raffone E, Rizzo P, et al. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol 2011; 27:857-61.
40. Hemadi M, Shokri S, Pourmatroud E, et al. Follicular dynamic and immunoreactions of the vitrified ovarian graft after host treatment with variable regimens of melatonin. Am J Reprod Immunol 2012; 67:401-12.
41. Jahnke G, Marr M, Myers C, et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999; 50:271-9.
42. Gonciarz M, Gonciarz Z, Bielanski W, et al. The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study. J Physiol Pharmacol 2012; 63:35-40.
43. de Lourdes V, Seabra M, Bignotto M, et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000; 29:193-200.
44. Goldberg-Stern H, Oren H, Peled N, et al. Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study. J Child Neurol 2012; 27:1524-8.
45. Del Fabbro E, Dev R, Hui D, et al. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol 2013; 31:1271-6.
46. Voordouw B, Euser R, Verdonk R, et al. Melatonin and melatoninprogestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin EndocrinolMetab 1992; 74:108-17.
47. Weaver D. Reproductive safety of melatonin: a "wonder drug" to wonder about. J Biol Rhythms 1997; 12:682.
48. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted reproductive technology fertility clinic success rates report. Atlanta, GA: US Dept of Health and Human Services, 2013.
49. Sampaio R, Conceição S, Miranda M, et al. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro. Reprod Biol Endocrinol 2012; 10:103.
50. Brzezinski A, Seibel MM, Lynch HJ, et al. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987; 64:865-7.
51. Ronnberg L, Kauppila A, Leppaluoto J, et al. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 1990; 71:492-6.
52. Ciotta L, Stracquadanio M, Pagano I, et al. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 2011; 15:509-14.
53. Nishihara T, Hashimoto S, Ito K, et al. Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol 2014; 30:359-62.
54. Chan A, Tetzlaff J, Gøtzsche P, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ2013; 346: e7586.
55. Clarke JF, van Rumste MM, Farquhar CM, et al. Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates? Fertil Steril 2010; 94:1647-51.
56. Reyner L, Horne J. Falling asleep whilst driving: are drivers aware of prior sleepiness? Int J Legal Med 1998; 111:120-3.
57. Altman D, Bland J. Treatment allocation by minimisation. BMJ 2005; 330:843.
58. Mills E, Chan A, Wu P, et al. Design, analysis, and presentation of crossover trials. Trials 2009; 10; 27.
59. Piantadosi S. Clinical trials: a methodologic perspective. Wiley series in probability and statistics. 2nd edn. John Wiley & Sons, 2013.
60. Waldhauser F, Waldhauser M, Lieberman H, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984; 39:307-13.